Metraipolis › archive › dc_59d91d2b3ef1
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein — Europe PMC PPR:PPR117896
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR117896
- DOI
- 10.1101/2020.03.15.992883
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-09T05:29:09.945Z
- SHA-256 of the archived text
aa22011bf72eea1e061769e51d619b3789838ff905b3e0b8cadf44b51d7e7a67- Stable URL of this page
https://metraipolis.com/documento/dc_59d91d2b3ef1
How to cite
A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein — Europe PMC PPR:PPR117896 — Europe PMC, https://europepmc.org/article/PPR/PPR117896 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_59d91d2b3ef1 (Metraipolis archive dc_59d91d2b3ef1, sha256 aa22011bf72eea1e061769e51d619b3789838ff905b3e0b8cadf44b51d7e7a67)
BibTeX
@misc{dc59d91d2b3ef1,
title = {A Cryptic Site of Vulnerability on the Receptor Binding Domain of the SARS-CoV-2 Spike Glycoprotein — Europe PMC PPR:PPR117896},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR117896},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_59d91d2b3ef1; sha256 aa22011bf72eea1e061769e51d619b3789838ff905b3e0b8cadf44b51d7e7a67},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR117896. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
SUMMARY: SARS-CoV-2 is a zoonotic virus that has caused a pandemic of severe respiratory disease—COVID-19— within several months of its initial identification. Comparable to the first SARS-CoV, this novel coronavirus’s surface Spike (S) glycoprotein mediates cell entry via the human ACE-2 receptor, and, thus, is the principal target for the development of vaccines and immunotherapeutics. Molecular information on the SARS-CoV-2 S glycoprotein remains limited. Here we report the crystal structure of the SARS-CoV-2 S receptor-binding-domain (RBD) at a the highest resolution to date, of 1.95 Å. We identified a set of SARS-reactive monoclonal antibodies with cross-reactivity to SARS-CoV-2 RBD and other betacoronavirus S glycoproteins. One of these antibodies, CR3022, was previously shown to synergize with antibodies that target the ACE-2 binding site on the SARS-CoV RBD and reduce viral escape capacity. We determined the structure of CR3022, in complex with the SARS-CoV-2 RBD, and defined a broadly reactive epitope that is highly conserved across betacoronaviruses. This epitope is inaccessible in the “closed” prefusion S structure, but is accessible in “open” conformations. This first-ever resolution of a human antibody in complex with SARS-CoV-2 and the broad reactivity of this set of antibodies to a conserved betacoronavirus epitope will allow antigenic assessment of vaccine candidates, and provide a framework for accelerated vaccine, immunotherapeutic and diagnostic strategies against SARS-CoV-2 and related betacoronaviruses. HIGHLIGHTS: High resolution structure of the SARS-CoV-2 Receptor-Binding-Domain (RBD). Recognition of the SARS-CoV-2 RBD by SARS-CoV antibodies. Structure of the SARS-COV-2 RBD in complex with antibody CR3022. Identification of a cryptic site of vulnerability on the SARS-CoV-2 Spike. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: bioRxiv, 2020 (prima pubblicazione 2020-03-17). Identificativi: DOI 10.1101/2020.03.15.992883. Pagina: https://europepmc.org/article/PPR/PPR117896 — https://doi.org/10.1101/2020.03.15.992883. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-09T05:25:56.221Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.